Corbus Pharmaceuticals
CRBP
CRBP
79 hedge funds and large institutions have $62.5M invested in Corbus Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 17 increasing their positions, 29 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
79
Holders Change
-7
Holders Change %
-8.14%
% of All Funds
1.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
17
Reduced
29
Closed
21
Calls
$138K
Puts
$161K
Net Calls
-$23K
Net Calls Change
+$51K
Top Buyers
| 1 |
Morgan Stanley
New York
|
$1.1M |
| 2 |
HP
HealthInvest Partners
Stockholm,
Sweden
|
$1.21M |
| 3 |
Millennium Management
New York
|
$1.1M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
$496K |
| 5 |
Aberdeen Group
Edinburgh,
United Kingdom
|
$498K |
Top Sellers
| 1 |
BlackRock
New York
|
$2.43M |
| 2 |
Renaissance Technologies
New York
|
$1.06M |
| 3 |
State Street
Boston,
Massachusetts
|
$380K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
$926K |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
$196K |
